Fibrous dysplasia of the jaw and diffuse large B-cell lymphoma coexistence, diagnosis and treatment experience and analysis: a case report. (PubMed, Front Surg) - Oct 11, 2026 - "She received 8 cycles of polatuzumab vedotin, rituximab, cyclophosphamide, doxorubicin hydrochloride and prednisone (Pola-R-CHP) chemotherapy, achieving partial relief of symptoms and reduced mandibular mass, but residual lesions remained. Subsequently, second-line dexamethasone, high-dose cytarabine and cisplatin (DHAP) salvage therapy was initiated due to persistent disease activity...First-line chemoimmunotherapy may achieve partial remission in refractory cases, and second-line intensive salvage regimens are needed for persistent disease. This case provides a reference for the diagnosis and treatment of similar rare complex cases."
Journal • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • Pain
|
|
Chaowei Zhang; Na Chen; Qing Hong; Weiyi Yao; Xinyu Tang; Yanan Zhu; Yuxuan Han
|